These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 2500234

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity.
    Abbruzzese JL, Levin B, Ajani JA, Faintuch JS, Pazdur R, Saks S, Edwards C, Gutterman JU.
    J Biol Response Mod; 1990 Oct; 9(5):522-7. PubMed ID: 2123922
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A phase I/II study of recombinant tumor necrosis factor and recombinant interferon gamma in patients with AIDS-related complex.
    Kaplan LD, Abrams DI, Sherwin SA, Kahn J, Volberding PA.
    Biotechnol Ther; 1990 Oct; 1(3):229-36. PubMed ID: 2562651
    [Abstract] [Full Text] [Related]

  • 6. Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
    Lenzi R, Rosenblum M, Verschraegen C, Kudelka AP, Kavanagh JJ, Hicks ME, Lang EA, Nash MA, Levy LB, Garcia ME, Platsoucas CD, Abbruzzese JL, Freedman RS.
    Clin Cancer Res; 2002 Dec; 8(12):3686-95. PubMed ID: 12473577
    [Abstract] [Full Text] [Related]

  • 7. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Dec; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 8. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.
    Atkins MB, Robertson MJ, Gordon M, Lotze MT, DeCoste M, DuBois JS, Ritz J, Sandler AB, Edington HD, Garzone PD, Mier JW, Canning CM, Battiato L, Tahara H, Sherman ML.
    Clin Cancer Res; 1997 Mar; 3(3):409-17. PubMed ID: 9815699
    [Abstract] [Full Text] [Related]

  • 9. Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects.
    Budd GT, Osgood B, Barna B, Boyett JM, Finke J, Medendorp SV, Murthy S, Novak C, Sergi J, Tubbs R.
    Cancer Res; 1989 Nov 15; 49(22):6432-6. PubMed ID: 2804986
    [Abstract] [Full Text] [Related]

  • 10. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
    Murren J, Modiano M, Clairmont C, Lambert P, Savaraj N, Doyle T, Sznol M.
    Clin Cancer Res; 2003 Sep 15; 9(11):4092-100. PubMed ID: 14519631
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I study of recombinant human tumor necrosis factor-alpha in patients with advanced malignancies.
    Bartsch HH, Nagel GA, Mull R, Flener R, Pfizenmaier K.
    Mol Biother; 1988 Sep 15; 1(1):21-9. PubMed ID: 3267369
    [Abstract] [Full Text] [Related]

  • 13. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
    Gridley DS, Slater JM, Stickney DR.
    J Biol Response Mod; 1989 Dec 15; 8(6):593-602. PubMed ID: 2513378
    [Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor in advanced gastrointestinal neoplasms. A clinical trial with a focus on haematological effects.
    Muc-Wierzgoń M, Baranowski M, Madej K.
    Haematologia (Budap); 1996 Dec 15; 27(2):85-92. PubMed ID: 14651225
    [Abstract] [Full Text] [Related]

  • 15. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ, Shpall EJ, Raad II, Kantarjian HM, Champlin RE.
    Cancer; 2006 Jun 15; 106(12):2664-71. PubMed ID: 16691620
    [Abstract] [Full Text] [Related]

  • 16. Effects of MAb BW 494/32 and rTNF-a/rIFN-g alone and in combination in nude mice bearing xenografts of human gastrointestinal/pancreatic carcinomas.
    Klapdor R, Schwarzenberg O, Kühl JS, Franke N, Bahlo M.
    Strahlenther Onkol; 1989 Jul 15; 165(7):549-50. PubMed ID: 2501886
    [No Abstract] [Full Text] [Related]

  • 17. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Apr 15; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [Abstract] [Full Text] [Related]

  • 18. Phase II study of recombinant human tumor necrosis factor in colorectal carcinoma.
    Schaadt M, Pfreundschuh M, Lorscheidt G, Peters KM, Steinmetz T, Diehl V.
    J Biol Response Mod; 1990 Apr 15; 9(2):247-50. PubMed ID: 2341863
    [Abstract] [Full Text] [Related]

  • 19. A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignancies.
    Ohno R, Yamaguchi Y, Toge T, Kinouchi T, Kotake T, Shibata M, Kiyohara Y, Ikeda S, Fukui I, Gohchi A, Sugiyama Y, Saji S, Hazama S, Oka M, Ohnishi K, Ohhashi Y, Tsukagoshi S, Taguchi T.
    Clin Cancer Res; 2000 Jul 15; 6(7):2661-9. PubMed ID: 10914707
    [Abstract] [Full Text] [Related]

  • 20. Synergistic enhancement of the antitumor activity of recombinant human TNF-alpha by recombinant human IFN-gamma.
    Taguchi T, Abe S, Nakano K, Matsui Y, Sohmura Y.
    Cancer Detect Prev; 1988 Jul 15; 12(1-6):105-14. PubMed ID: 3141050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.